Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
20.43
+0.61 (3.08%)
May 15, 2026, 4:00 PM EDT - Market closed
Sensei Biotherapeutics Employees
As of December 31, 2024, Sensei Biotherapeutics had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 13 or -46.43% compared to the previous year.
Employees
15
Change (1Y)
-13
Growth (1Y)
-46.43%
Revenue / Employee
n/a
Profits / Employee
-$12,297,133
Market Cap
27.38M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 15 | -13 | -46.43% | 14 | 1 |
| Dec 31, 2023 | 28 | 0 | - | 27 | 1 |
| Dec 31, 2022 | 28 | -28 | -50.00% | 28 | 0 |
| Dec 31, 2021 | 56 | 24 | 75.00% | 56 | 0 |
| Dec 31, 2020 | 32 | - | - | 30 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| Werewolf Therapeutics | 39 |
| Kyntra Bio | 34 |
| Jasper Therapeutics | 22 |
| Lisata Therapeutics | 21 |
| ABVC BioPharma | 19 |
| Outlook Therapeutics | 17 |
| Serina Therapeutics | 13 |
SNSE News
- 2 days ago - Sensei Biotherapeutics reports Q1 EPS ($131.45) vs ($5.45) last year - TheFly
- 2 days ago - Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - Business Wire
- 12 days ago - Sensei Biotherapeutics announces first patient dosed in FTH-PIK-101 trial - TheFly
- 12 days ago - Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer - Business Wire
- 19 days ago - Sensei Biotherapeutics files to sell 24.87M shares of common stock for holders - TheFly
- 4 weeks ago - Sensei Biotherapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 5 weeks ago - Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 6 weeks ago - Sensei Biotherapeutics reports FY25 EPS ($16.72) vs ($24.01) last year - TheFly